Increased MIF expression has been correlated clinically with aggressive disease or increased tumor angiogenesis in patients with melanoma (9), glioblastomas (10), non–small cell lung cancer, and head and neck cancer (11, 12). The gene discussed is MIF; the disease is neoplasm.